Danaher Co. (NYSE:DHR) Shares Bought by Institute for Wealth Management LLC.

Institute for Wealth Management LLC. lifted its position in Danaher Co. (NYSE:DHR) by 3.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,752 shares of the conglomerate’s stock after acquiring an additional 126 shares during the period. Institute for Wealth Management LLC.’s holdings in Danaher were worth $663,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of the company. Creative Financial Designs Inc. ADV acquired a new position in Danaher during the second quarter worth $44,000. Fortem Financial Group LLC boosted its stake in Danaher by 3.7% during the second quarter. Fortem Financial Group LLC now owns 7,457 shares of the conglomerate’s stock worth $1,319,000 after buying an additional 265 shares during the last quarter. Engineers Gate Manager LP acquired a new position in Danaher during the first quarter worth $1,180,000. Private Trust Co. NA boosted its stake in Danaher by 1.9% during the second quarter. Private Trust Co. NA now owns 20,279 shares of the conglomerate’s stock worth $3,643,000 after buying an additional 386 shares during the last quarter. Finally, Ellevest Inc. boosted its stake in Danaher by 91.0% during the second quarter. Ellevest Inc. now owns 1,207 shares of the conglomerate’s stock worth $213,000 after buying an additional 575 shares during the last quarter. 77.67% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities analysts have weighed in on DHR shares. Royal Bank of Canada boosted their price objective on Danaher from $205.00 to $218.00 and gave the stock an “outperform” rating in a research note on Friday, July 24th. Robert W. Baird lifted their target price on Danaher from $163.00 to $205.00 and gave the company an “outperform” rating in a research report on Friday, July 24th. Citigroup lifted their target price on Danaher from $180.00 to $190.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Credit Suisse Group lifted their target price on Danaher from $165.00 to $169.00 and gave the company an “outperform” rating in a research report on Thursday, May 21st. Finally, Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $195.00 target price on the stock in a research report on Tuesday, June 16th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $197.73.

In other Danaher news, EVP Daniel L. Comas sold 100,032 shares of the company’s stock in a transaction dated Monday, July 27th. The stock was sold at an average price of $194.56, for a total transaction of $19,462,225.92. Following the sale, the executive vice president now owns 134,933 shares in the company, valued at approximately $26,252,564.48. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Robert S. Lutz sold 33,892 shares of the company’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $161.68, for a total value of $5,479,658.56. Following the sale, the chief accounting officer now owns 18,950 shares in the company, valued at approximately $3,063,836. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 498,929 shares of company stock worth $94,446,919. 11.70% of the stock is owned by company insiders.

Shares of DHR stock traded up $1.66 on Friday, hitting $203.80. The stock had a trading volume of 1,792,914 shares, compared to its average volume of 2,377,988. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.20 and a quick ratio of 1.74. The firm has a market capitalization of $142.15 billion, a P/E ratio of 43.64, a P/E/G ratio of 3.23 and a beta of 0.92. Danaher Co. has a 1 year low of $119.60 and a 1 year high of $204.13. The company’s 50 day moving average price is $182.24 and its 200-day moving average price is $161.95.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Thursday, July 23rd. The conglomerate reported $1.44 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.09 by $0.35. Danaher had a return on equity of 11.88% and a net margin of 17.73%. The firm had revenue of $5.30 billion for the quarter, compared to the consensus estimate of $5.01 billion. During the same quarter in the previous year, the business earned $1.09 EPS. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. On average, equities analysts forecast that Danaher Co. will post 5.42 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Friday, June 26th were issued a dividend of $0.18 per share. The ex-dividend date was Thursday, June 25th. This represents a $0.72 annualized dividend and a yield of 0.35%. Danaher’s dividend payout ratio (DPR) is 16.29%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Further Reading: Market Capitalization and Individual Investors

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.